Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders

Clinical trial NCT02502903 · COMPLETED

Trial details

NCT number: NCT02502903
Sponsor: Bioverativ, a Sanofi company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bullous Pemphigoid (BP)Cold Agglutinin Disease (CAD)Warm Autoimmune Hemolytic Anemia (WAIHA)End-stage Renal Disease (ESRD)

Start date: 2015-07-13
Primary completion: 2021-03-31
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.